Indeed, a single topical treatment with GSK3787, which covalently binds and permanently inactivates PPARδ showed similar therapeutic efficacy as several topical applications with GSK0660 in mice with psoriasis-like skin inflammation [64,100]. This evidence concerns the gene PPARD and dermatitis.